2022

1. Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

   Annals of Oncology, Vol. 33, Núm. 1, pp. 67-79